期刊文献+

脂蛋白相关磷脂酶A2与颈动脉粥样硬化和颈内动脉短暂性脑缺血发作的关系

Association between Lp-PLA2 and carotid atherosclerosis and transient ischemic attack of internal carotid artery system
原文传递
导出
摘要 目的研究脂蛋白相关磷脂酶A2(Lp—PLA2)和颈动脉超声对短暂性脑缺血发作(TIA)的诊断价值。方法以90例急性期颈内动脉系统TIA患者(TIA组)和55例健康体检者(正常对照组)为研究对象,应用颈动脉超声检测颈动脉内膜情况,应用酶联免疫吸附测定法(ELISA)检测血清Lp-PLA2,并进行统计学比较。结果TIA组颈动脉粥样硬化斑块检出率显著高于正常对照组[分别为78.9%(71/90)与29.1%(16/55),X^2=35.27,P〈0.01]。正常对照组颈动脉粥样硬化斑块总数35块,其中不稳定斑块6块,稳定斑块29块;TIA组颈动脉粥样硬化斑块总数134块,其中不稳定斑块103块,稳定斑块3l块,TIA组不稳定斑块构成比显著高于正常对照组(X^2=43.22,P〈0.01)。TIA组男性和女性血清Lp—PLA2分别为(19.08±7.92)、(15.15±4.91)mob/(min·m1),正常对照组男性和女性血清Lp-PLA2分别为(13.86±3.15)、(11.18±2.96)mo]/(min·m1),TIA组均显著高于相应正常对照组(t值分别为3.8598、2.9260,P均〈0.01),且TIA组和正常对照组血清Lp-PLA2男性均显著高于女性(t值分别为2.3850、2.9143,P均〈0.05)。TIA组不稳定斑块组血清Lp.PLA2为(20.16壬6.76)mol/(min·m1),稳定斑块组血清Lp—PLA2为(16.09±4.15)mol/(min·m1),2组比较差异有统计学意义(t=2.5578,P〈0.05)。结论血清Lp-PLA2是颈动脉斑块的一种危险因素,联合Lp—PLA2检测和颈动脉超声检查可以预警TIA的发生。 Objective To evaluate the diagnostic value of lipoprotein-associated phospholipase A2 ( Lp- PLA2) and carotid artery ultra sound for transient ischemic-attack (TIA) . Methods Ninety patients with TIA of internal carotid artery system in the acute phase and 55 normal control subjects were recruited. Their carotid intima-media thicknesses were assessed by carotid uhrasonography. Serum Lp-PLA2 levels were determined by enzyme-linked immunosorbentassay(ELISA) , and all the data were compared between the two group. Results The detection rate of carotid atherosclerotic plaque in the TIA group was significantly higher than that in the control group [78.9% (71/90) vs. 29. 1% (16/55), X^2 = 35.27, P 〈 0.01] .There were 35 carotid atherosclerotic plaque in the control group, of which 6 were unstable plaques and 29 were stable plaques. There were 134 carotid atherosclerotie plaque in the TIA group,of which 103 were unstable plaques and 31 were stable plaques, the constituent ratio of unstable plaque in the TIA group was significantly higher than that in the control group(X^2 =43. 22,P 〈 0. 01 ). The levels of serum Lp-PLA2 in male and female patients in TIA group were ( [ 19.08±7. 92] mol/( min·ml) and [ 15.15±4. 91 ] mol/( min·ml), which were significantly higher than those in male and female in the control group ( E 13.86±3.15 ] tool/( min·ml) and [11.18±2. 96 ] mol/ ( min·ml) ( t = 3. 8598 and 2. 9260, respectively, Ps 〈 0. 01 ). Furthermore, the levels of serum Lp-PLA2 of males in the TIA group and control group were significantly higher than that of females in the TIA group and control group( t = 2. 3850 and 2. 9143, respectively, Ps 〈 0. 05 ). The level of serum Lp-PLA2 in unstable olaque patients in the TIA group was (20. 16±6. 76 )mol/( min·ml), which was significantly higher than that in stable plaque patients in the TIA group was (16. 09±4. 15) mol/(min·ml) ,the difference was satistically significant (t = 2. 5578, P 〈 0. 05 ). Conclusion Serum Lp-PLA2 is a risk factor of carotid atherosclerotic plaque, the combination of Lp-PLA2 and carotid ultrosonography can be used and alert indicator of TIA.
作者 李丽
出处 《中国综合临床》 2011年第6期596-599,共4页 Clinical Medicine of China
关键词 短暂性脑缺血发作 脂蛋白相关磷脂酶A2 颈动脉超声检查 Transient ischemic attack Lipoprotein-associated phospholipase A2 Carotid ultrosonography
  • 相关文献

参考文献15

  • 1Macphee CH,Nelson J,Zalewski A.Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target[J].Curr Opin Pharmacol,2006,6 (2):154-161.
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 3Nandalur KR,Hardie AD,Raghavan P,et al.Composition of the stable carotid plaque; insights from a multidetector computed tomography study of plaque volume[J].Stroke,2007,38(3):935-940.
  • 4Easlon JD,Saver JL,Albers GW,et al.Definition and evaluation of transient ischemic attack:a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease.The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists[J].Stroke,2009,40(6):2276-2293.
  • 5尚明谦,曹秉振.颈动脉粥样硬化与缺血性脑卒中的研究进展[J].临床神经病学杂志,2005,18(5):399-400. 被引量:54
  • 6Dahl A,Lund C,Russell D.Atherosclerosis and cerebral infarction[J].Tidsskr Nor Laegeforen,2007,127(7):892-896.
  • 7Powers WJ,Grubb RL Jr,Raichle ME.Clinical results of extracranial-intracranial bypass surgery in patients with hemodynamic cerebrovascular disease[J].J Neurosurg,1989,70(1):61-67.
  • 8Verhoeven B,Hellings WE,Moll FL,et al.Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients[J].J Vasc Surg,2005,42 (6):1075-1081.
  • 9胡威威,李海涛.血清脂蛋白相关磷脂酶A_2水平与冠心病关系[J].中国循证心血管医学杂志,2010,2(1):21-24. 被引量:19
  • 10娄卫东,谢紫明,孙伟.缺血性脑血管病急性期血浆溶血磷脂酸水平的变化[J].中国基层医药,2010,17(7):865-866. 被引量:5

二级参考文献39

  • 1楼小亮,詹细平,李晓萍,徐江霞,范华,龚淑琪,谭建萍,刘海江,徐剑君.血浆溶血磷脂酸水平与缺血性脑卒中预后关系的研究[J].中华危重病急救医学,2008,20(11). 被引量:10
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 3Banach M,Markuszewski L,Zaslonka J,et al.The role of inflammation in the pathogenesis of atherosclerosis.Przegl Epidemiol,2004,58:663-670.
  • 4Gensini CG.A more meaningful scoring system for determining the severity of coronary heart disease.Am J Cardiol,1983,51:606.
  • 5Caslake MJ,Packard CJ,Suckling KE,et al.Lipoprotein-associated phospho1ipase A2,platelet-activating factor acetylhydrolase:a potential new risk factor for coronary artery disease.Atherosclerosis,2000,150:413-419.
  • 6Zalewski A,Macphee C.Role of lipoprotein-associated phospholipase A2 in atherosclerosis:biology,epidemiology,and possibletherapeutic target.Arterioscler Thromb Vasc Biol,2005,25:923-931.
  • 7Kolodgie FD,Burke AP,Skorija KS,et al.Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis.Arterioscler Thromb Vasc Bio,2006,26:2523-2529.
  • 8Packard CJ,O'Reilly DS,Caslake MJ,et al.Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.West of Scotland Coronary Prevention Study Group.N Engl J Med,2000,343:1148-1155.
  • 9Koenig W,Khuseyinova N,Lowel H,et al.Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population:results from the14-year follow-up of a large cohort from southern Germany.Circulation,2004,110:1903-1908.
  • 10Ballantyne CM,Hoogeveen RC,Bang H,et al.Lipoprotein-associated phospholipase A2,high-sensitivity C-reactive protein,and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.Circulation,2004,109:837-842.

共引文献33095

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部